Ebos Group (Ebos Group) Debt-to-Equity : 0.78 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Ebos Group Debt-to-Equity?

Ebos Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $152 Mil. Ebos Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1,077 Mil. Ebos Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $1,585 Mil. Ebos Group's debt to equity for the quarter that ended in Dec. 2023 was 0.78.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Ebos Group's Debt-to-Equity or its related term are showing as below:

EBOSF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.25 Med: 0.52 Max: 0.78
Current: 0.78

During the past 13 years, the highest Debt-to-Equity Ratio of Ebos Group was 0.78. The lowest was 0.25. And the median was 0.52.

EBOSF's Debt-to-Equity is ranked worse than
71.08% of 83 companies
in the Medical Distribution industry
Industry Median: 0.29 vs EBOSF: 0.78

Ebos Group Debt-to-Equity Historical Data

The historical data trend for Ebos Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Debt-to-Equity Chart

Ebos Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

0.43

0.62

0.48

0.73

0.53

Ebos Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.25	0.73	0.58	0.53	0.78

Competitive Comparison of Ebos Group's Debt-to-Equity

For the Medical Distribution subindustry, Ebos Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ebos Group's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Ebos Group's Debt-to-Equity falls into.

Ebos Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Ebos Group's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(61.601	+	794.947)	/	1625.304
	=	0.53

Ebos Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(152.477	+	1077.256)	/	1584.826
	=	0.78

Ebos Group (OTCPK:EBOSF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Ebos Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Ebos Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group (Ebos Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (OTCPK:EBOSF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

EBO:New Zealand EJG:Germany EBO:Australia

Address

108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (Ebos Group) Headlines

From GuruFocus

Half Year 2024 EBOS Group Ltd Earnings Call Transcript

By GuruFocus Research • 02-28-2024